Moderna expects six major vaccine product launches in the next few years, each with significant addressable markets. The annual global endemic COVID-19 booster market alone is estimated by Moderna to be approximately $15 billon.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRNA: